<HashMap><database>biostudies-literature</database><scores/><additional><submitter>RadioRoux Collaborative</submitter><funding>Royal College of Surgeons of Edinburgh</funding><funding>Cancer Research UK Cambridge RadNet</funding><pagination>zraf078</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12416563</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>9(5)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Oesophageal squamous cell carcinoma is the predominant histopathological subtype of oesophageal cancer across the world, representing as many as 90% of all cases; however, within Western cohorts, it is a low-prevalence disease, and, as such, appropriately powered trials to establish a standard treatment paradigm in this population remain challenging. The aim of this study was to assess current practices and compare outcomes for patients with locally advanced oesophageal squamous cell carcinoma across the UK and Ireland.&lt;h4>Methods&lt;/h4>This was a retrospective multicentre cohort study of patients managed with curative intent for squamous cell carcinoma of the middle or distal oesophagus in 23 hospitals across the UK and Ireland. Consecutive patients diagnosed between 1 Ja</pubmed_abstract><journal>BJS open</journal><pubmed_title>Tolerability, toxicity, and outcomes following surgical and non-surgical approaches to the management of patients with locally advanced oesophageal squamous cell carcinoma: multicentre retrospective cohort study.</pubmed_title><pmcid>PMC12416563</pmcid><funding_grant_id>C17918/A28870</funding_grant_id><pubmed_authors>Markar S</pubmed_authors><pubmed_authors>Akbari K</pubmed_authors><pubmed_authors>Mohammed R</pubmed_authors><pubmed_authors>Fackrell D</pubmed_authors><pubmed_authors>Matcha N</pubmed_authors><pubmed_authors>Kapiris M</pubmed_authors><pubmed_authors>Krishnamoorthy A</pubmed_authors><pubmed_authors>Wilson I</pubmed_authors><pubmed_authors>Charlton P</pubmed_authors><pubmed_authors>Ahmed M</pubmed_authors><pubmed_authors>Nijjar R</pubmed_authors><pubmed_authors>Hughes M</pubmed_authors><pubmed_authors>Noormohamed S</pubmed_authors><pubmed_authors>Tewari N</pubmed_authors><pubmed_authors>Gall L</pubmed_authors><pubmed_authors>Aswad M</pubmed_authors><pubmed_authors>Alyacoubi S</pubmed_authors><pubmed_authors>Rayner C</pubmed_authors><pubmed_authors>Mahmood R</pubmed_authors><pubmed_authors>Al-Khyatt W</pubmed_authors><pubmed_authors>Bundred J</pubmed_authors><pubmed_authors>McGuinness L</pubmed_authors><pubmed_authors>Owen R</pubmed_authors><pubmed_authors>Walker S</pubmed_authors><pubmed_authors>Radhakrishna G</pubmed_authors><pubmed_authors>Walker R</pubmed_authors><pubmed_authors>Glaysher M</pubmed_authors><pubmed_authors>Theophilidou E</pubmed_authors><pubmed_authors>Han NW</pubmed_authors><pubmed_authors>Lo T</pubmed_authors><pubmed_authors>Hyland L</pubmed_authors><pubmed_authors>Doe M</pubmed_authors><pubmed_authors>Germain L</pubmed_authors><pubmed_authors>Evans RPT</pubmed_authors><pubmed_authors>Hogan K</pubmed_authors><pubmed_authors>Williams P</pubmed_authors><pubmed_authors>Thomas B</pubmed_authors><pubmed_authors>Miller G</pubmed_authors><pubmed_authors>Knight W</pubmed_authors><pubmed_authors>Lada H</pubmed_authors><pubmed_authors>Khanzada Z</pubmed_authors><pubmed_authors>Cockbain A</pubmed_authors><pubmed_authors>Jones C</pubmed_authors><pubmed_authors>Griffiths EA</pubmed_authors><pubmed_authors>Grace B</pubmed_authors><pubmed_authors>Elliott JA</pubmed_authors><pubmed_authors>Sarantitis I</pubmed_authors><pubmed_authors>Edwards G</pubmed_authors><pubmed_authors>Sayers J</pubmed_authors><pubmed_authors>Livings C</pubmed_authors><pubmed_authors>Chow K</pubmed_authors><pubmed_authors>Kaushal D</pubmed_authors><pubmed_authors>Webber N</pubmed_authors><pubmed_authors>Maynard N</pubmed_authors><pubmed_authors>Crotty F</pubmed_authors><pubmed_authors>Samuel R</pubmed_authors><pubmed_authors>Hingorani M</pubmed_authors><pubmed_authors>Mehta A</pubmed_authors><pubmed_authors>Kershaw M</pubmed_authors><pubmed_authors>Hoque M</pubmed_authors><pubmed_authors>Jaunoo S</pubmed_authors><pubmed_authors>Hamid M</pubmed_authors><pubmed_authors>Raveendran S</pubmed_authors><pubmed_authors>Chien S</pubmed_authors><pubmed_authors>Kamarajah SK</pubmed_authors><pubmed_authors>Reynolds J</pubmed_authors><pubmed_authors>Pucher P</pubmed_authors><pubmed_authors>Singh P</pubmed_authors><pubmed_authors>McIntosh D</pubmed_authors><pubmed_authors>Maharaj G</pubmed_authors><pubmed_authors>Crosby T</pubmed_authors><pubmed_authors>Goh YM</pubmed_authors><pubmed_authors>Kandiah K</pubmed_authors><pubmed_authors>Poon-King A</pubmed_authors><pubmed_authors>Coe P</pubmed_authors><pubmed_authors>Otter D</pubmed_authors><pubmed_authors>RadioRoux Collaborative</pubmed_authors><pubmed_authors>Jones P</pubmed_authors><pubmed_authors>Dunn J</pubmed_authors><pubmed_authors>Barrington C</pubmed_authors><pubmed_authors>Siddique H</pubmed_authors><pubmed_authors>Sultan J</pubmed_authors><pubmed_authors>Irwin A</pubmed_authors><pubmed_authors>Anwer A</pubmed_authors><pubmed_authors>Lessing J</pubmed_authors><pubmed_authors>Newport D</pubmed_authors><pubmed_authors>Viswanath N</pubmed_authors><pubmed_authors>Kisiel A</pubmed_authors><pubmed_authors>Upchurch E</pubmed_authors><pubmed_authors>Gossage J</pubmed_authors><pubmed_authors>Roulston K</pubmed_authors><pubmed_authors>Growcott S</pubmed_authors><pubmed_authors>Penney N</pubmed_authors><pubmed_authors>Sudin E</pubmed_authors><pubmed_authors>Pursnani K</pubmed_authors><pubmed_authors>Mori G</pubmed_authors><pubmed_authors>Murphy J</pubmed_authors><pubmed_authors>Abbas H</pubmed_authors><pubmed_authors>Trust H</pubmed_authors><pubmed_authors>Uppal S</pubmed_authors><pubmed_authors>Aghadiuno T</pubmed_authors><pubmed_authors>Walther J</pubmed_authors><pubmed_authors>Goody R</pubmed_authors><pubmed_authors>Underwood TJ</pubmed_authors><pubmed_authors>Jackson N</pubmed_authors><pubmed_authors>Khan A</pubmed_authors><pubmed_authors>Prathap S</pubmed_authors><pubmed_authors>Blencowe N</pubmed_authors><pubmed_authors>Brown L</pubmed_authors><pubmed_authors>Azam S</pubmed_authors><pubmed_authors>Boddy A</pubmed_authors><pubmed_authors>Gwynne S</pubmed_authors><pubmed_authors>Gomez N</pubmed_authors><pubmed_authors>Helbrow J</pubmed_authors></additional><is_claimable>false</is_claimable><name>Tolerability, toxicity, and outcomes following surgical and non-surgical approaches to the management of patients with locally advanced oesophageal squamous cell carcinoma: multicentre retrospective cohort study.</name><description>&lt;h4>Background&lt;/h4>Oesophageal squamous cell carcinoma is the predominant histopathological subtype of oesophageal cancer across the world, representing as many as 90% of all cases; however, within Western cohorts, it is a low-prevalence disease, and, as such, appropriately powered trials to establish a standard treatment paradigm in this population remain challenging. The aim of this study was to assess current practices and compare outcomes for patients with locally advanced oesophageal squamous cell carcinoma across the UK and Ireland.&lt;h4>Methods&lt;/h4>This was a retrospective multicentre cohort study of patients managed with curative intent for squamous cell carcinoma of the middle or distal oesophagus in 23 hospitals across the UK and Ireland. Consecutive patients diagnosed between 1 Ja</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Sep</publication><modification>2026-06-02T02:44:20.317Z</modification><creation>2026-04-13T03:12:43.042Z</creation></dates><accession>S-EPMC12416563</accession><cross_references><pubmed>40920998</pubmed><doi>10.1093/bjsopen/zraf078</doi></cross_references></HashMap>